From: Depression and anxiety in epilepsy: the association with demographic and seizure-related variables
95% Confidence interval | ||||||
---|---|---|---|---|---|---|
Factor | Unstandardized coefficient | Lower bound | Upper bound | Standardized coefficients | p Value | R2 |
Gender | 2.851 | 1.018 | 4.684 | 0.212 | 0.002 | 0.045 |
Seizure frequency > 1/month | 3.858 | 1.726 | 5.990 | 0.245 | < 0.001 | 0.060 |
Seizure frequency < 1/year | -0.093 | -2.105 | 1.920 | -0.006 | 0.928 | 0 |
Seizure frequency > 1/year | -2.761 | -4.609 | -0.913 | -0.204 | 0.004 | 0.042 |
Symptomatic focal epilepsy | 3.521 | 1.711 | 5.331 | 0.262 | < 0.001 | 0.069 |
Cryptogenic focal epilepsy | -2.657 | -4.727 | -0.587 | -0.177 | 0.012 | 0.031 |
Idiopathic generalized epilepsy | -2.090 | -4.358 | 0.178 | -0.128 | 0.071 | 0.016 |
Antiepileptic drug 1 | -2.277 | -4.126 | -0.429 | -0.170 | 0.016 | 0.029 |
Antiepileptic drug 2 | 0.695 | -1.271 | 2.661 | 0.049 | 0.487 | 0.002 |
Antiepileptic drug 3 | 3.242 | 0.649 | 5.834 | 0.172 | 0.015 | 0.030 |
Age | -0.032 | -0.126 | 0.062 | -0.048 | 0.499 | 0.002 |
Duration of disease | 0.047 | -0.053 | 0.147 | 0.066 | 0.356 | 0.004 |